Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 9 個月前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients
ACCESSWIRE· 11 個月前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in ...
Yahoo奇摩 網頁搜尋
- 12 個搜尋結果
